ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 160 filers reported holding ITEOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 6.56 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $358,372 | -38.2% | 32,728 | -25.3% | 0.00% | -25.0% |
| Q2 2023 | $579,938 | -1.3% | 43,802 | +1.5% | 0.00% | 0.0% |
| Q1 2023 | $587,571 | -33.1% | 43,172 | -4.0% | 0.00% | -42.9% |
| Q4 2022 | $878,733 | +102435.9% | 44,994 | 0.0% | 0.01% | 0.0% |
| Q3 2022 | $857 | -99.9% | 44,994 | +19.8% | 0.01% | 0.0% |
| Q2 2022 | $774,000 | -36.0% | 37,570 | 0.0% | 0.01% | 0.0% |
| Q1 2022 | $1,209,000 | – | 37,570 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
| MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
| Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
| Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
| RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
| Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
| BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
| AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
| Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
| 683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |